Results 251 to 260 of about 79,213 (303)
Patterns of presentation and diagnostic delays in biliary tract cancers: a real-world European study. [PDF]
ESMO Gastrointest OncolMartirena A +3 more
europepmc +1 more source
Comparative Analytical Performance and Clinical Agreement of Chemiluminescence Microparticle Immunoassay and Electrochemiluminescence Immunoassay for CA19-9: A Diagnostic Accuracy Study. [PDF]
Diagnostics (Basel)Wongpiyabovorn J +2 more
europepmc +1 more source
Digestive and Liver Disease, 2011 Background: Very few studies assessed cholangiocarcinoma clinical characteristics. Aim: To evaluate the clinical characteristics of intra-hepatic (IH) and extra-hepatic (EH)-CCA. Methods: We performed a national survey based on a questionnaire.
Marco Marzioni +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Gastroenterology, 2005
Cholangiocarcinoma is a devastating malignancy that presents late, is notoriously difficult to diagnose, and is associated with a high mortality. The incidence of intrahepatic cholangiocarcinoma is increasing worldwide. The cause for this rise is unclear, although it could be related to an interplay between predisposing genetic factors and ...
Konstantinos N, Lazaridis +1 more
+7 more sources
Cholangiocarcinoma is a devastating malignancy that presents late, is notoriously difficult to diagnose, and is associated with a high mortality. The incidence of intrahepatic cholangiocarcinoma is increasing worldwide. The cause for this rise is unclear, although it could be related to an interplay between predisposing genetic factors and ...
Konstantinos N, Lazaridis +1 more
+7 more sources
Surgical Clinics of North America, 2019
Cholangiocarcinoma is a rare malignancy and accounts for 2% of all malignancies. Incidence is on the increase in the Western world. Cholangiocarcinoma arises from the malignant growth of the epithelial lining of the bile ducts and can be found all along the biliary tree.
Leigh Anne Dageforde
exaly +3 more sources
Cholangiocarcinoma is a rare malignancy and accounts for 2% of all malignancies. Incidence is on the increase in the Western world. Cholangiocarcinoma arises from the malignant growth of the epithelial lining of the bile ducts and can be found all along the biliary tree.
Leigh Anne Dageforde
exaly +3 more sources
Critical Reviews in Oncology/Hematology, 2009
Cholangiocarcinoma is an uncommon adenocarcinoma with poor prognosis. Although the 1-year survival has increased over time, the 5-year survival has not shown any significant change (less than 5%). Cure can only be expected from surgical resection of early stage tumours but most patients initially present with advanced disease.
Stefania, Mosconi +5 more
openaire +2 more sources
Cholangiocarcinoma is an uncommon adenocarcinoma with poor prognosis. Although the 1-year survival has increased over time, the 5-year survival has not shown any significant change (less than 5%). Cure can only be expected from surgical resection of early stage tumours but most patients initially present with advanced disease.
Stefania, Mosconi +5 more
openaire +2 more sources
Surgical Clinics of North America
Cholangiocarcinoma (CC) is a heterogeneous group of malignancies that originates at any point along the biliary tree. CC is an uncommon malignancy as it represents approximately 3% of all gastrointestinal malignancies, though its global incidence is rising.
Matthew E, Dixon +2 more
openaire +4 more sources
Cholangiocarcinoma (CC) is a heterogeneous group of malignancies that originates at any point along the biliary tree. CC is an uncommon malignancy as it represents approximately 3% of all gastrointestinal malignancies, though its global incidence is rising.
Matthew E, Dixon +2 more
openaire +4 more sources